Healthcare [ 13/13 ] | Medical Instruments & Supplies [ 140/164 ]
NYSE MKT | Common Stock
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.
The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room.
In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters.
Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components.
It markets its products through direct sales force, distributors, and sales agents.
The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures.
Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 4, 24 | -0.07 Decreased by -16.67% | -0.07 |
| Nov 9, 23 | -0.07 Increased by 0.00% | -0.06 Decreased by -16.67% |
| Aug 10, 23 | -0.07 Increased by 0.00% | -0.07 |
| May 9, 23 | -0.07 Decreased by -16.67% | -0.06 Decreased by -16.67% |
| Mar 3, 23 | -0.06 Decreased by -20.00% | -0.07 Increased by +14.29% |
| Nov 10, 22 | -0.07 Increased by 0.00% | -0.06 Decreased by -16.67% |
| Aug 9, 22 | -0.07 Decreased by -40.00% | -0.06 Decreased by -16.67% |
| May 10, 22 | -0.06 Decreased by -200.00% | -0.06 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 4.57 M Decreased by -37.47% | -5.04 M Decreased by -30.84% | Decreased by -110.41% Decreased by -109.26% |
| Sep 30, 23 | 7.80 M Increased by +1.85% | -5.71 M Decreased by -19.34% | Decreased by -73.18% Decreased by -17.17% |
| Jun 30, 23 | 7.86 M Increased by +27.75% | -4.96 M Increased by +2.59% | Decreased by -63.07% Increased by +23.75% |
| Mar 31, 23 | 6.55 M Decreased by -6.95% | -4.92 M Decreased by -20.38% | Decreased by -75.06% Decreased by -29.37% |
| Dec 31, 22 | 7.30 M Decreased by -11.40% | -3.85 M Decreased by -14.84% | Decreased by -52.76% Decreased by -29.62% |
| Sep 30, 22 | 7.66 M Decreased by -15.92% | -4.78 M Decreased by -3.54% | Decreased by -62.45% Decreased by -23.14% |
| Jun 30, 22 | 6.15 M Decreased by -32.03% | -5.09 M Decreased by -320.44% | Decreased by -82.72% Decreased by -518.59% |
| Mar 31, 22 | 7.04 M Decreased by -18.39% | -4.08 M Decreased by -166.45% | Decreased by -58.02% Decreased by -226.48% |